Oleg Akilov

Assistant Professor

University of Pittsburgh School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Oleg Akilov is an Assistant Professor at the University of Pittsburgh School of Medicine in the United States. His research focuses on dermatopathology, particularly in the context of cutaneous T-cell lymphomas, including mycosis fungoides and Sézary syndrome. He has published extensively on immunotherapy responses, diagnostic challenges, and evolving tumor cell characteristics in these conditions.

Articles (17)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (8)

Hessel H. van der Zee

NETHERLANDS

View details

Christiane Querfeld

Beckman Research Institute, City of Hope

UNITED STATES

View details

Angela Minic

Senior Professional Research Assistant

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Steven Rosen

Provost & Chief Scientific Officer

City of Hope

UNITED STATES

View details

Robert Gniadecki

Professor

Bispebjerg Hospital

DENMARK

View details

Francine Foss

UNITED STATES

View details

Larisa Geskin

UNITED STATES

View details

Youn H. Kim

Stanford University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Oleg Akilov

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Dermatopathological Challenges in Objectively Characterizing Immunotherapy Response in Mycosis Fungoides

Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome

The odyssey of diagnosis of mycosis fungoides: Sailing beyond clonality and histology

Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon

Utility of Low-Dose Duvelisib for Advanced Mycosis Fungoides: A Single-Institution Study

Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T Cell Lymphoma

CD5+ Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, Presenting as an Asymptomatic Nodule

CD8+ T Lymphocytes in Hypopigmented Mycosis Fungoides: Malignant Cells or Reactive Clone?

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?

Understanding Cell Lines, Patient-Derived Xenograft and Genetically Engineered Mouse Models Used to Study Cutaneous T-Cell Lymphoma

Targeting the CD47-SIRPα Axis: Present Therapies and the Future for Cutaneous T-cell Lymphoma

Repetitive expanded T‐cell receptor clonotypes impart the classic T helper 2 Sézary cell phenotype

Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project

Exhausted Markers in Cutaneous T-Cell Lymphoma: The Face that Launched a Thousand Ships

Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4+ BTLA+ T Cells in Tumor Microenvironment of Mycosis Fungoides

The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides.

Collaborators (8)

Hessel H. van der Zee

Christiane Querfeld

Angela Minic

Steven Rosen

Robert Gniadecki

Francine Foss

Larisa Geskin

Youn H. Kim

Make your next move.